If radiation or chemotherapy treatment of leukaemias or lymphomas does not bring sufficient success, the transplantation of bone marrow or blood stem cells is usually the only chance of cure. Unfortunately, the majority of patients die despite transplantation, often due to spontaneous infections, transplant versus recipient reactions and recurrences. New predictive models for the individual course of disease, as developed in the "XplOit" research project, predict the occurrence and extent of these risks and thus enable transplantation physicians to intervene at an early stage to save lives in dreaded complications.
Project network provides innovative IT platform for clinical data integration, model development and Validation -
Presentation of research results at the annual meeting of the European Society for Blood and Bone Marrow Transplantation
The new data integration, model development and validation platform "XplOit", which is provided by a project network under the leadership of the Fraunhofer Institute for Biomedical Engineering IBMT, facilitates the development and verification of these prediction models.
The innovative platform prepares data sets in such a way that they can be used for systems medicine research. Through effective predictive models for complications after stem cell transplantation, the joint project "XplOit" creates the basis for the future use of artificial intelligence in transplantation medicine.
The "XplOit" consortium will present its project results on March 25 at the 45th Annual Meeting of the European Society for Blood and Marrow Transplantation in Frankfurt, Germany (Messe Frankfurt, Forum level C, Room Kolleg, 2:30-3:45 pm, http://www.xploit-idsem.de/xploit-workshop-auf-dem-ebmt-am-25-maerz-2019.html). The first predictive AI models for allogeneic stem cell therapy provide sustainable results and will be presented at a workshop together with the "XplOit" platform.
New and effective prediction models
The "XplOit" platform has been tailored over the last 3 years for the development and validation of predictive models to improve treatment after stem cell transplantation. The transplantation of haematopoietic stem cells from donors is used, for example, for the treatment of various forms of leukaemia. Disease relapses are feared.
The first precise prediction models, which individually predict possible complications for each patient, will be available in the "XplOit" platform in 2019. This will enable life-threatening complications to be identified more quickly and treated earlier than today, such as the dreaded transplant vs. host reaction. Project coordinator Stephan Kiefer explains: "The comprehensive analysis of patient data creates for the first time the option for predicting individual disease progression. With the prototypes of the prediction models, we will enter clinical validation in March and refine our results."
The BMBF project "XplOit" facilitates and accelerates the time-consuming process of providing and combining clinical data, developing and validating models, and making them available for clinical use. A newly developed generation of advanced semantic data integration and information extraction tools makes this easier.
Predictive models can help clinicians diagnose and treat their patients. To develop these mathematical predictive models, a wide variety of clinical patient data from the information systems must be collected, harmonized and analyzed on a large scale. In the present project "XplOit", data protection is ensured when dealing with personal and sensitive patient information.
The complex prediction models obtained from the analysis of the data are first validated in the further course of the project and checked for their prediction accuracy before they can be used successfully in practice.
Partnership-based research for XplOit
The joint project "XplOit" is implemented by an internationally experienced, multidisciplinary team of experts from the fields of medicine, systems biology, computer linguistics as well as medical and bioinformatics. It is coordinated by the Fraunhofer Institute for Biomedical Engineering IBMT, which is in charge of the development of the "XplOit" platform and contributes core components to information extraction, integration and analysis.
The Institute for Formal Ontologies and Medical Information Science at Saarland University is primarily responsible for the platform's semantic integration framework. The company Averbis contributes tools for information extraction from clinical text documentations. Computer scientists from the Department of Pediatric Oncology and Hematology at Saarland University are responsible for data protection and develop pseudonymization tools and the system's modelling workbench.
The model development itself is carried out by the Medical Informatics Methods Department of the Eberhard-Karls-University Tübingen and the Clinical Pharmacy Department of the Saarland University. Clinical expertise and data are provided by the Clinic for Bone Marrow Transplantation and the Institute for Virology of the University Hospital Essen as well as by the Clinic for Internal Medicine I - Oncology, Hematology, Clinical Immunology, Rheumatology and the Institute for Virology of the University of Saarland. From March 2019, the clinical partners will validate the predictive models for stem cell transplantation developed with the help of the "XplOit" platform, coordinated by the Institute of Virology at Saarland University
XplOit is funded within the initiative i:DSem - Integrative Data Semantics in Systems Medicine by the Federal Ministry of Education and Research.
Duration: 01.03.2016 - 28.02.2021, Project website: http://www.xploit-idsem.de/
The Fraunhofer Institute for Biomedical Engineering IBMT is a device and technology developer for the solution of individual research and development tasks in the fields of biomedical/medical engineering, molecular and cellular biotechnology, bioprocesses & bioanalytics, cryo(bio)technology and nano(bio)technology, ultrasound technology, biomedical microsystems, neuroprosthetics and implants, health information systems, theranostics, (mobile) laboratory technology as well as laboratory automation including inline/online process monitoring. The Fraunhofer IBMT has been working in the field of stem cell research for more than 15 years and has extensive cell line stocks in industrially and clinically structured biobanks for the cryogenic storage of valuable samples (liquids, cells, tissue fragments).
Dipl.-Inform. Stephan Kiefer
Fraunhofer Institute for Biomedical Engineering
Project Coordinator XplOit
Telephone: +49 (0) 6897/9071-406
http://www.xploit-idsem.de/xploit-workshop-auf-dem-ebmt-am-25-maerz-2019.html (March 25, 2019 at the 45th Annual Meeting of the European Society for Blood and Marrow Transplantation in Frankfurt, Germany
http://www.xploit-idsem.de/ (Project Website)
Dipl.-Phys. Annette Maurer-von der Gathen | Fraunhofer-Institut für Biomedizinische Technik IBMT
Chip-based optical sensor detects cancer biomarker in urine
05.12.2019 | The Optical Society
Scientist identify new marker for insecticide resistance in malaria mosquitoes
05.12.2019 | Liverpool School of Tropical Medicine
With ultracold chemistry, researchers get a first look at exactly what happens during a chemical reaction
The coldest chemical reaction in the known universe took place in what appears to be a chaotic mess of lasers. The appearance deceives: Deep within that...
Abnormal scarring is a serious threat resulting in non-healing chronic wounds or fibrosis. Scars form when fibroblasts, a type of cell of connective tissue, reach wounded skin and deposit plugs of extracellular matrix. Until today, the question about the exact anatomical origin of these fibroblasts has not been answered. In order to find potential ways of influencing the scarring process, the team of Dr. Yuval Rinkevich, Group Leader for Regenerative Biology at the Institute of Lung Biology and Disease at Helmholtz Zentrum München, aimed to finally find an answer. As it was already known that all scars derive from a fibroblast lineage expressing the Engrailed-1 gene - a lineage not only present in skin, but also in fascia - the researchers intentionally tried to understand whether or not fascia might be the origin of fibroblasts.
Fibroblasts kit - ready to heal wounds
Research from a leading international expert on the health of the Great Lakes suggests that the growing intensity and scale of pollution from plastics poses serious risks to human health and will continue to have profound consequences on the ecosystem.
In an article published this month in the Journal of Waste Resources and Recycling, Gail Krantzberg, a professor in the Booth School of Engineering Practice...
Conventional light microscopes cannot distinguish structures when they are separated by a distance smaller than, roughly, the wavelength of light. Superresolution microscopy, developed since the 1980s, lifts this limitation, using fluorescent moieties. Scientists at the Max Planck Institute for Polymer Research have now discovered that graphene nano-molecules can be used to improve this microscopy technique. These graphene nano-molecules offer a number of substantial advantages over the materials previously used, making superresolution microscopy even more versatile.
Microscopy is an important investigation method, in physics, biology, medicine, and many other sciences. However, it has one disadvantage: its resolution is...
03.12.2019 | Event News
15.11.2019 | Event News
15.11.2019 | Event News
05.12.2019 | Life Sciences
05.12.2019 | Life Sciences
05.12.2019 | Materials Sciences